BioPharm International - May 2022

BioPharm International- May 2022

Issue link: https://www.e-digitaleditions.com/i/1467950

Contents of this Issue

Navigation

Page 3 of 35

4 BioPharm International May 2022 eBook www.biopharminternational.com What Outsourcing Partners Wish You Knew Industry experts share their top outsourcing tips from both the perspective of companies offering outsourcing services as well as for companies looking to outsource. I n the modern bio/pharmaceutical industry, countless ser- vices are outsourced, including manufacturing, process development, scale-up, regulatory compliance assistance, analytical services, software and cloud services, and much more. But what should companies looking to outsource know prior to selecting vendors and partners? In addition, what should the companies that are outsourcing services be aware of? BioPharm International interviewed David Heiger, asso- ciate VP, Agilent CrossLab Group; Nandu Deorkar, vice president of R&D production, Avantor; Sébastien Ribault, vice president and head of end-to-end solutions, Life Science business of Merck KGaA, Darmstadt, Germany; Angelo Filosa, PhD, portfolio director, professional and technol- ogy services OneSource, PerkinElmer; and Christoph Zehe, research fellow, advanced cell biology, Sartorius Corporate Research, on what outsourcing partners wish you knew. WHAT COMPANIES OFFERING OUTSOURCING SERVICES SHOULD KNOW BioPharm: W hat are your top recommendations for companies offering outsourcing services? Filosa (PerkinElmer): Clearly define what you want to outsource and why. Classify activities as core to your work and non-core and then identify partners that have expertise in the non-core activities that are a strategic aspect to how you run your business so your internal team can focus on the science you are advancing. Decide whether to insource or outsource. Once you have identified the non-core activities, then you need to decide whether they are outsourced or insourced and what needs to be supported on-site or can be done remotely. Certain activities are non-core but still must be done onsite for various reasons. This process is part of def ining your MEG RIVERS Partnerships for Outsourcing Outsourcing Dzmitry - STOCK.ADOBE.COM

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - May 2022 - BioPharm International- May 2022